Herceptin will be a big breakthrough. It's coming out now in the U.S...soon in Canada.

Herceptin is the first monoclonal antibody for breast cancer.

It targets HER2...a protein that stimulates the growth of breast cancer cells. About 30% of women with breast cancer have tumours that produce excessive amounts of HER2.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote